Progress | Published:

Molecular mechanisms of CRISPR–Cas spacer acquisition

Nature Reviews Microbiology (2018) | Download Citation

Abstract

Many bacteria and archaea have the unique ability to heritably alter their genomes by incorporating small fragments of foreign DNA, called spacers, into CRISPR loci. Once transcribed and processed into individual CRISPR RNAs, spacer sequences guide Cas effector nucleases to destroy complementary, invading nucleic acids. Collectively, these two processes are known as the CRISPR–Cas immune response. In this Progress article, we review recent studies that have advanced our understanding of the molecular mechanisms underlying spacer acquisition and that have revealed a fundamental link between the two phases of CRISPR immunity that ensures optimal immunity from newly acquired spacers. Finally, we highlight important open questions and discuss the potential basic and applied impact of spacer acquisition research.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Additional information

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Thomas, C. M. & Nielsen, K. M. Mechanisms of, and barriers to, horizontal gene transfer between bacteria. Nat. Rev. Microbiol. 3, 711–721 (2005).

  2. 2.

    Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709–1712 (2007).

  3. 3.

    Marraffini, L. A. & Sontheimer, E. J. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322, 1843–1845 (2008).

  4. 4.

    Amitai, G. & Sorek, R. CRISPR-Cas adaptation: insights into the mechanism of action. Nat. Rev. Microbiol. 14, 67–76 (2016).

  5. 5.

    Jackson, S. A. et al. CRISPR-Cas: adapting to change. Science 356, eaal5056 (2017).

  6. 6.

    Sternberg, S. H., Richter, H., Charpentier, E. & Qimron, U. Adaptation in CRISPR-Cas systems. Mol. Cell 61, 797–808 (2016).

  7. 7.

    Koonin, E. V., Makarova, K. S. & Zhang, F. Diversity, classification and evolution of CRISPR-Cas systems. Curr. Opin. Microbiol. 37, 67–78 (2017).

  8. 8.

    Krupovic, M., Beguin, P. & Koonin, E. V. Casposons: mobile genetic elements that gave rise to the CRISPR-Cas adaptation machinery. Curr. Opin. Microbiol. 38, 36–43 (2017).

  9. 9.

    Nunez, J. K. et al. Cas1-Cas2 complex formation mediates spacer acquisition during CRISPR-Cas adaptive immunity. Nat. Struct. Mol. Biol. 21, 528–534 (2014).

  10. 10.

    Nunez, J. K., Harrington, L. B., Kranzusch, P. J., Engelman, A. N. & Doudna, J. A. Foreign DNA capture during CRISPR-Cas adaptive immunity. Nature 527, 535–538 (2015).

  11. 11.

    Wang, J. et al. Structural and mechanistic basis of PAM-dependent spacer acquisition in CRISPR-Cas systems. Cell 163, 840–853 (2015).

  12. 12.

    Wright, A. V. et al. Structures of the CRISPR genome integration complex. Science 357, 1113–1118 (2017).

  13. 13.

    Xiao, Y., Ng, S., Nam, K. H. & Ke, A. How type II CRISPR-Cas establish immunity through Cas1–Cas2-mediated spacer integration. Nature 550, 137–141 (2017).

  14. 14.

    Wright, A. V. & Doudna, J. A. Protecting genome integrity during CRISPR immune adaptation. Nat. Struct. Mol. Biol. 23, 876–883 (2016).

  15. 15.

    Nunez, J. K., Lee, A. S., Engelman, A. & Doudna, J. A. Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity. Nature 519, 193–198 (2015).

  16. 16.

    Arslan, Z., Hermanns, V., Wurm, R., Wagner, R. & Pul, U. Detection and characterization of spacer integration intermediates in type I-E CRISPR-Cas system. Nucleic Acids Res. 42, 7884–7893 (2014).

  17. 17.

    Ivancic-Bace, I., Cass, S. D., Wearne, S. J. & Bolt, E. L. Different genome stability proteins underpin primed and naive adaptation in E. coli CRISPR-Cas immunity. Nucleic Acids Res. 43, 10821–10830 (2015).

  18. 18.

    Yosef, I., Goren, M. G. & Qimron, U. Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res. 40, 5569–5576 (2012).

  19. 19.

    McGinn, J. & Marraffini, L. A. CRISPR-Cas systems optimize their immune response by specifying the site of spacer integration. Mol. Cell 64, 616–623 (2016).

  20. 20.

    Weinberger, A. D. et al. Persisting viral sequences shape microbial CRISPR-based immunity. PLoS Comput. Biol. 8, e1002475 (2012).

  21. 21.

    Deltcheva, E. et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471, 602–607 (2011).

  22. 22.

    Elmore, J. R. et al. Programmable plasmid interference by the CRISPR-Cas system in Thermococcus kodakarensis. RNA Biol. 10, 828–840 (2013).

  23. 23.

    Nickel, L. et al. Two CRISPR-Cas systems in Methanosarcina mazei strain Go1 display common processing features despite belonging to different types I and III. RNA Biol. 10, 779–791 (2013).

  24. 24.

    Randau, L. RNA processing in the minimal organism Nanoarchaeum equitans. Genome Biol. 13, R63 (2012).

  25. 25.

    Richter, H. et al. Characterization of CRISPR RNA processing in Clostridium thermocellum and Methanococcus maripaludis. Nucleic Acids Res. 40, 9887–9896 (2012).

  26. 26.

    Jones, D. L. et al. Kinetics of dCas9 target search in Escherichia coli. Science 357, 1420–1424 (2017).

  27. 27.

    Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C. & Doudna, J. A. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507, 62–67 (2014).

  28. 28.

    Kupczok, A., Landan, G. & Dagan, T. The contribution of genetic recombination to CRISPR array evolution. Genome Biol. Evol. 7, 1925–1939 (2015).

  29. 29.

    Tyson, G. W. & Banfield, J. F. Rapidly evolving CRISPRs implicated in acquired resistance of microorganisms to viruses. Environ. Microbiol. 10, 200–2007 (2008).

  30. 30.

    Richter, C. et al. Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer. Nucleic Acids Res. 42, 8516–8526 (2014).

  31. 31.

    Rollie, C., Schneider, S., Brinkmann, A. S., Bolt, E. L. & White, M. F. Intrinsic sequence specificity of the Cas1 integrase directs new spacer acquisition. eLife https://doi.org/10.7554/eLife.08716 (2015).

  32. 32.

    Nunez, J. K., Bai, L., Harrington, L. B., Hinder, T. L. & Doudna, J. A. CRISPR immunological memory requires a host factor for specificity. Mol. Cell 62, 824–833 (2016).

  33. 33.

    Rollie, C., Graham, S., Rouillon, C. & White, M. F. Prespacer processing and specific integration in a Type I-A CRISPR system. Nucleic Acids Res. 46, 1007–1020 (2018).

  34. 34.

    Chylinski, K., Makarova, K. S., Charpentier, E. & Koonin, E. V. Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Res. 42, 6091–6105 (2014).

  35. 35.

    Wei, Y., Chesne, M. T., Terns, R. M. & Terns, M. P. Sequences spanning the leader-repeat junction mediate CRISPR adaptation to phage in Streptococcus thermophilus. Nucleic Acids Res. 43, 1749–1758 (2015).

  36. 36.

    Levy, A. et al. CRISPR adaptation biases explain preference for acquisition of foreign DNA. Nature 520, 505–510 (2015).

  37. 37.

    Paez-Espino, D. et al. Strong bias in the bacterial CRISPR elements that confer immunity to phage. Nat. Commun. 4, 1430 (2013).

  38. 38.

    Bikard, D., Hatoum-Aslan, A., Mucida, D. & Marraffini, L. A. CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. Cell Host Microbe 12, 177–186 (2012).

  39. 39.

    Edgar, R. & Qimron, U. The Escherichia coli CRISPR system protects from λ lysogenization, lysogens, and prophage induction. J. Bacteriol. 192, 6291–6294 (2010).

  40. 40.

    Jiang, W., Bikard, D., Cox, D., Zhang, F. & Marraffini, L. A. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31, 233–239 (2013).

  41. 41.

    Modell, J. W., Jiang, W. & Marraffini, L. A. CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity. Nature 544, 101–104 (2017).

  42. 42.

    Dillingham, M. S. & Kowalczykowski, S. C. RecBCD enzyme and the repair of double-stranded DNA breaks. Microbiol. Mol. Biol. Rev. 72, 642–671 (2008).

  43. 43.

    Yeeles, J. T., van Aelst, K., Dillingham, M. S. & Moreno-Herrero, F. Recombination hotspots and single-stranded DNA binding proteins couple DNA translocation to DNA unwinding by the AddAB helicase-nuclease. Mol. Cell 42, 806–816 (2011).

  44. 44.

    Fagerlund, R. D. et al. Spacer capture and integration by a type I-F Cas1-Cas2-3 CRISPR adaptation complex. Proc. Natl Acad. Sci. USA 114, E5122–E5128 (2017).

  45. 45.

    Künne, T. et al. Cas3-derived target DNA degradation fragments fuel primed CRISPR adaptation. Mol. Cell 63, 852–864 (2016).

  46. 46.

    Musharova, O. et al. Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation. Nucleic Acids Res. 45, 3297–3307 (2017).

  47. 47.

    Babu, M. et al. A dual function of the CRISPR-Cas system in bacterial antivirus immunity and DNA repair. Mol. Microbiol. 79, 484–502 (2011).

  48. 48.

    Heler, R. et al. Cas9 specifies functional viral targets during CRISPR-Cas adaptation. Nature 519, 199–202 (2015).

  49. 49.

    Hynes, A. P., Villion, M. & Moineau, S. Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages. Nat. Commun. 5, 4399 (2014).

  50. 50.

    Heler, R. et al. Mutations in Cas9 enhance the rate of acquisition of viral spacer sequences during the CRISPR-Cas immune response. Mol. Cell 65, 168–175 (2017).

  51. 51.

    Hoyland-Kroghsbo, N. M. et al. Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system. Proc. Natl Acad. Sci. USA 114, 131–135 (2017).

  52. 52.

    Patterson, A. G. et al. Quorum sensing controls adaptive immunity through the regulation of multiple CRISPR-Cas systems. Mol. Cell 64, 1102–1108 (2016).

  53. 53.

    Deveau, H. et al. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J. Bacteriol. 190, 1390–1400 (2008).

  54. 54.

    Mojica, F. J., Diez-Villasenor, C., Garcia-Martinez, J. & Almendros, C. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 155, 733–740 (2009).

  55. 55.

    Elmore, J. R. et al. Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system. Genes Dev. 30, 447–459 (2016).

  56. 56.

    Marraffini, L. A. & Sontheimer, E. J. Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature 463, 568–571 (2010).

  57. 57.

    Pyenson, N. C., Gayvert, K., Varble, A., Elemento, O. & Marraffini, L. A. Broad targeting specificity during bacterial Type III CRISPR-Cas immunity constrains viral escape. Cell Host Microbe 22, 343–353 (2017).

  58. 58.

    Goldberg, G. W., Jiang, W., Bikard, D. & Marraffini, L. A. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting. Nature 514, 633–637 (2014).

  59. 59.

    Samai, P. et al. Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity. Cell 161, 1164–1174 (2015).

  60. 60.

    Deng, L., Garrett, R. A., Shah, S. A., Peng, X. & She, Q. A novel interference mechanism by a type IIIB CRISPR-Cmr module in Sulfolobus. Mol. Microbiol. 87, 1088–1099 (2013).

  61. 61.

    Peng, W., Feng, M., Feng, X., Liang, Y. X. & She, Q. An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference. Nucleic Acids Res. 43, 406–417 (2015).

  62. 62.

    Kieper, S. N. et al. Cas4 facilitates PAM-compatible spacer selection during CRISPR adaptation. Cell Rep. 22, 3377–3384 (2018).

  63. 63.

    Lee, H., Zhou, Y., Taylor, D. W. & Sashital, D. G. Cas4-dependent prespacer processing ensures high-fidelity programming of CRISPR arrays. Mol. Cell 70, 48–59 (2018).

  64. 64.

    Shiimori, M., Garrett, S. C., Graveley, B. R. & Terns, M. P. Cas4 nucleases define the PAM, length, and orientation of DNA fragments integrated at CRISPR loci. Mol. Cell 70, 814–824 (2018).

  65. 65.

    Silas, S. et al. Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase-Cas1 fusion protein. Science 351, aad4234 (2016).

  66. 66.

    Fineran, P. C. et al. Degenerate target sites mediate rapid primed CRISPR adaptation. Proc. Natl Acad. Sci. USA 111, E1629–E1638 (2014).

  67. 67.

    Rollins, M. F. et al. Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity. Proc. Natl Acad. Sci. USA 114, E5113–E5121 (2017).

  68. 68.

    Westra, E. R. et al. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol. Cell 46, 595–605 (2012).

  69. 69.

    Semenova, E. et al. Highly efficient primed spacer acquisition from targets destroyed by the Escherichia coli type I-E CRISPR-Cas interfering complex. Proc. Natl Acad. Sci. USA 113, 7626–7631 (2016).

  70. 70.

    Staals, R. H. et al. Interference-driven spacer acquisition is dominant over naive and primed adaptation in a native CRISPR-Cas system. Nat. Commun. 7, 12853 (2016).

  71. 71.

    Redding, S. et al. Surveillance and processing of foreign DNA by the Escherichia coli CRISPR-Cas system. Cell 163, 854–865 (2015).

  72. 72.

    Blosser, T. R. et al. Two distinct DNA binding modes guide dual roles of a CRISPR-Cas protein complex. Mol. Cell 58, 60–70 (2015).

  73. 73.

    Xue, C. et al. CRISPR interference and priming varies with individual spacer sequences. Nucleic Acids Res. 43, 10831–10847 (2015).

  74. 74.

    Xue, C., Whitis, N. R. & Sashital, D. G. Conformational control of cascade interference and priming activities in CRISPR immunity. Mol. Cell 64, 826–834 (2016).

  75. 75.

    Severinov, K., Ispolatov, I. & Semenova, E. The influence of copy-number of targeted extrachromosomal genetic elements on the outcome of CRISPR-Cas defense. Front. Mol. Biosci. 3, 45 (2016).

  76. 76.

    Datsenko, K. A. et al. Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat. Commun. 3, 945 (2012).

  77. 77.

    Swarts, D. C., Mosterd, C., van Passel, M. W. & Brouns, S. J. CRISPR interference directs strand specific spacer acquisition. PLoS ONE 7, e35888 (2012).

  78. 78.

    Mohanraju, P. et al. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science 353, aad5147 (2016).

  79. 79.

    Shipman, S. L., Nivala, J., Macklis, J. D. & Church, G. M. Molecular recordings by directed CRISPR spacer acquisition. Science 353, aaf1175 (2016).

  80. 80.

    Shipman, S. L., Nivala, J., Macklis, J. D. & Church, G. M. CRISPR-Cas encoding of a digital movie into the genomes of a population of living bacteria. Nature 547, 345–349 (2017).

  81. 81.

    Sheth, R. U., Yim, S. S., Wu, F. L. & Wang, H. H. Multiplex recording of cellular events over time on CRISPR biological tape. Science 358, 1457–1461 (2017).

  82. 82.

    Shmakov, S. A. et al. The CRISPR spacer space is dominated by sequences from species-specific mobilomes. mBio 8, e01397–17 (2017).

  83. 83.

    Silas, S. et al. On the origin of reverse transcriptase-using CRISPR-Cas systems and their hyperdiverse, enigmatic spacer repertoires. mBio 8, e00897–17 (2017).

Download references

Acknowledgements

The authors thank the members of the laboratory for helpful discussions. J.M. is supported by a US National Science Foundation Graduate Research Fellowship. L.A.M. is supported by a Burroughs Wellcome PATH Award, a National Institutes of Health (NIH) Director’s Pioneer Award (DP1GM128184-01) and an HHMI-Simons Faculty Scholar Award.

Reviewer information

Nature Reviews Microbiology thanks K. Severinov and the other anonymous reviewer(s) for their contribution to the peer review of this work.

Author information

Affiliations

  1. Laboratory of Bacteriology, The Rockefeller University, New York, NY, USA

    • Jon McGinn
    •  & Luciano A. Marraffini

Authors

  1. Search for Jon McGinn in:

  2. Search for Luciano A. Marraffini in:

Contributions

J.M. researched data for the article. J.M. and L.A.M. made substantial contributions to discussions of the content, wrote the article and reviewed and/or edited the manuscript before submission.

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to Luciano A. Marraffini.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/s41579-018-0071-7